Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Louisiana Blue | 00947 deuruxolitinib (Leqselvi)PayerPolicy · BCBSLA-00947-E8C1B05782 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00946 rilpivirine tablet for suspension (Edurant PED)PayerPolicy · BCBSLA-00946-D785C6CD68 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00945 Firvanq (vancomycin for oral solution)PayerPolicy · BCBSLA-00945-ACE6A50F72 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00944 Tolsura (itraconazole)PayerPolicy · BCBSLA-00944-4DFEECBDA5 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00943 Select Calcipotriene ProductsPayerPolicy · BCBSLA-00943-F75F423102 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00942 nipocalimab-aahu (Imaavy)PayerPolicy · BCBSLA-00942-28CA570133 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00941 olezarsen (Tryngolza)PayerPolicy · BCBSLA-00941-89397D2B0B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00940 lenacapavir (Yeztugo)PayerPolicy · BCBSLA-00940-8E550FAF9B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00939 diazoxide choline (Vykat XR)PayerPolicy · BCBSLA-00939-A7F94728FC | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00938 prademagene zamikeracel (Zevaskyn)PayerPolicy · BCBSLA-00938-7A8A1D6515 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00937 fitusiran (Qfitlia)PayerPolicy · BCBSLA-00937-9EB85AA7BD | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00936 atrasentan (Vanrafia)PayerPolicy · BCBSLA-00936-1807F5468F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00935 axatilimab-csfr (Niktimvo)PayerPolicy · BCBSLA-00935-C9D9AA6B84 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00934 Percutaneous Revascularization Procedures for Lower Extremity Peripheral Arterial Disease-Retired PolicyPayerPolicy · BCBSLA-00934-AF173D9CAA | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00933 remestemcl-L-rknd (Ryoncil)PayerPolicy · BCBSLA-00933-226A3F2E01 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00932 Journavx (suzetrigine)PayerPolicy · BCBSLA-00932-C076587E49 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00931 Transcatheter Tricuspid Valve Repair or ReplacementPayerPolicy · BCBSLA-00931-D7A3E1FA74 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00930 Balloon Spacers for Treatment of Irreparable Rotator Cuffs of the ShoulderPayerPolicy · BCBSLA-00930-465D19431D | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00929 acoramidis (Attruby)PayerPolicy · BCBSLA-00929-DC12905FE3 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00928 vanzacaftor/tezacaftor/deutivacaftor (Alyftrek)PayerPolicy · BCBSLA-00928-1E824802DE | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00927 crinecerfont (Crenessity)PayerPolicy · BCBSLA-00927-AEB6DEB4F1 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00926 Peripheral Nerve Injury Repair Using Synthetic Conduits or Processed Nerve AllograftsPayerPolicy · BCBSLA-00926-FAE6190B3F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00925 concizumab-mtci (Alhemo)PayerPolicy · BCBSLA-00925-05CD6FD975 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00924 marstacimab-hncq (Hympavzi)PayerPolicy · BCBSLA-00924-D8BEAA208D | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00923 Surgery for Groin Pain in AthletesPayerPolicy · BCBSLA-00923-48D580E406 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00922 lebrikizumab-lbkz (Ebglyss)PayerPolicy · BCBSLA-00922-E38114BB09 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00921 palopegteriparatide (Yorvipath)PayerPolicy · BCBSLA-00921-6E3C71D1D8 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00920 aprocitentan (Tryvio)PayerPolicy · BCBSLA-00920-C4FA77F144 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00919 arimoclomol (Miplyffa)PayerPolicy · BCBSLA-00919-276EE71DC6 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00918 levacetylleucine (Aqneursa)PayerPolicy · BCBSLA-00918-6B2CA6665A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00917 imetelstat (Rytelo)PayerPolicy · BCBSLA-00917-E52819058D | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00916 Radiofrequency Coblation Tenotomy and Percutaneous Ultrasonic Tenotomy for Musculoskeletal ConditionsPayerPolicy · BCBSLA-00916-47174C456E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00915 Chemical PeelsPayerPolicy · BCBSLA-00915-5855763FF0 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00914 nemolizumab-ilto (Nemluvio)PayerPolicy · BCBSLA-00914-5362D3A4E2 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00913 ensifentrine (Ohtuvayre)PayerPolicy · BCBSLA-00913-4242AFD2DF | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00912 Irreversible Electroporation and HistotripsyPayerPolicy · BCBSLA-00912-8B8B2C4EA7 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00911 afamitresgene autoleucel (Tecelra)PayerPolicy · BCBSLA-00911-450900B08D | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00910 Select Substance Abuse MedicationsPayerPolicy · BCBSLA-00910-7EDEA76EEA | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00909 Sofdra (sofpironium)PayerPolicy · BCBSLA-00909-E3D23824FD | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00908 Neffy (epinephrine nasal spray)PayerPolicy · BCBSLA-00908-27ACF0D4A5 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00907 Gonadotropin-releasing Hormone (GnRH) ProductsPayerPolicy · BCBSLA-00907-F34E33262A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00906 Enzyme Replacement Therapy for Fabry DiseasePayerPolicy · BCBSLA-00906-F80FDE19B1 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00905 Select Injectable risperidone ProductsPayerPolicy · BCBSLA-00905-A71DF9CB6E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00904 Alpha1 Proteinase InhibitorsPayerPolicy · BCBSLA-00904-4DEC7C30AC | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00903 crovalimab-akkz (PiaSky)PayerPolicy · BCBSLA-00903-D633F24467 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00902 danicopan (Voydeya)PayerPolicy · BCBSLA-00902-4976E7CEEB | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00901 Special Histochemical Stains and Immunohistochemical StainsPayerPolicy · BCBSLA-00901-DDBAB7F0F0 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00899 Periureteral Bulking Agents as a Treatment of Vesicoureteral RefluxPayerPolicy · BCBSLA-00899-03936F7B42 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00898 Alternative and Complementary TherapyPayerPolicy · BCBSLA-00898-FE911450A0 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00897 infliximab-dyyb (Zymfentra)PayerPolicy · BCBSLA-00897-7EEAC08B5A | New policy |
|---|